STOCKHOLDERS' EQUITY (Tables)

3 Months Ended

Nov. 30, 2020

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Arrangement, Option, Activity [Table Text Block]

			Weighted
		Weighted	Average	Aggregate
		Average	Remaining	Intrinsic
		Exercise Price	Contractual	Value
Options	Shares	$	Term	$
Outstanding at August 31, 2020	400,000	1.35	3.24	—
Granted	10,000	1.00	5.00	—
Outstanding at November 30, 2020	410,000	1.34	3.02	—
Exercisable at November 30, 2020	272,500	1.42	2.70	—

Schedule of Non-vested Stock Options Activity [Table Text Block]

			Weighted
			Average
			Grant Date
	Number of Options		Fair Value
			$
Non-vested options at August 31, 2020	203,750		0.48
Granted	10,000		0.34
Vested	(76,250	)	0.49
Non-vested options at November 30, 2020	137,500		0.47

Schedule of Stock-based Compensation Expense [Table Text Block]

	2020	2019
	$	$
Stock-based compensation
General and administrative	4,531	9,258
Sales and marketing	4,644	6,100
Product development	3,674	2,578
Total stock-based compensation	12,849	17,936

Schedule of Share-based Payment Award Using Black-Scholes Option-Pricing Model [Table Text Block]

	2020	2019
Expected term of stock options (years)	3.25	3.25
Expected volatility	105.4%	118.6%
Risk-free interest rate	0.35%	1.0%
Dividend yields	—	—
Weighted average grant date fair value	$0.34	$0.49